Hormone receptor expression in patients with dermatofibrosarcoma protuberans.

Area of Science:

• Oncology
• Dermatology
• Endocrinology

Background:

• Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer with unknown causes.
• Pregnancy-associated DFSP growth suggests a potential hormonal influence.

Purpose of the Study:

• To investigate the expression of estrogen receptors (ERs) and progesterone receptors (PRs) in DFSP.
• To explore the association between ER/PR expression and clinical factors in DFSP patients.

Main Methods:

• Analysis of 44 archived DFSP tissue samples using immunohistochemistry for ER and PR.
• Semiquantitative scoring to determine receptor positivity.
• Statistical analysis to correlate receptor status with tumor site, age, sex, race, and recurrence.

Main Results:

• ER and PR expression varied among DFSP tumors: 22.7% ER+/PR+, 34.1% ER+/PR-, 9.1% ER-/PR+, and 34.1% ER-/PR-.
• No significant association found between receptor expression and patient demographics or tumor location.
• Loss of ER/PR expression was observed in all recurrent DFSP cases.

Conclusions:

• Hormone receptor expression in DFSP is variable.
• Loss of ER/PR expression may be associated with DFSP recurrence.
• Further research is needed to understand hormone receptor function and explore anti-hormone therapies for DFSP.